Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 444

1.

[Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients].

Hüneburg R, Aretz S, Büttner R, Daum S, Engel C, Fechner G, Habermann JK, Heling D, Hoffmann K, Holinski-Feder E, Kloor M, von Knebel-Döberitz M, Loeffler M, Möslein G, Perne C, Redler S, Rieß O, Schmiegel W, Seufferlein T, Siebers-Renelt U, Steinke-Lange V, Tecklenburg J, Vangala D, Vilz T, Weitz J, Wiedenmann B, Strassburg CP, Nattermann J.

Z Gastroenterol. 2019 Nov;57(11):1309-1320. doi: 10.1055/a-1008-9827. Epub 2019 Nov 18. German.

PMID:
31739377
2.

Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?

Merola E, Rinke A, Partelli S, Gress TM, Andreasi V, Kollár A, Perren A, Christ E, Panzuto F, Pascher A, Jann H, Arsenic R, Cremer B, Kaemmerer D, Kump P, Lipp RW, Agaimy A, Wiedenmann B, Falconi M, Pavel ME.

Ann Surg Oncol. 2019 Nov 12. doi: 10.1245/s10434-019-08049-5. [Epub ahead of print]

PMID:
31720931
3.

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.

Leyden S, Kolarova T, Bouvier C, Caplin M, Conroy S, Davies P, Dureja S, Falconi M, Ferolla P, Fisher G, Goldstein G, Hicks RJ, Lawrence B, Majima Y, Metz DC, O'Toole D, Ruszniewski P, Wiedenmann B, Hollander R; International Neuroendocrine Cancer Alliance (INCA).

Int J Cancer. 2019 Sep 11. doi: 10.1002/ijc.32678. [Epub ahead of print]

PMID:
31509608
4.

Peritoneal carcinomatosis in gastro-entero-pancreatic neuroendocrine neoplasms: clinical impact and effectiveness of the available therapeutic options.

Merola E, Prasad V, Pascher A, Pape UF, Arsenic R, Denecke T, Fehrenbach U, Wiedenmann B, Pavel M.

Neuroendocrinology. 2019 Sep 5. doi: 10.1159/000503144. [Epub ahead of print]

PMID:
31484182
5.

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes.

Felder S, Jann H, Arsenic R, Denecke T, Prasad V, Knappe-Drzikova B, Maasberg S, Wiedenmann B, Pavel ME, Pascher A, Pape UF.

Endocr Relat Cancer. 2019 Jul 1. pii: ERC-18-0582.R2. doi: 10.1530/ERC-18-0582. [Epub ahead of print]

6.

R-spondin-3 induces secretory, antimicrobial Lgr5+ cells in the stomach.

Sigal M, Reinés MDM, Müllerke S, Fischer C, Kapalczynska M, Berger H, Bakker ERM, Mollenkopf HJ, Rothenberg ME, Wiedenmann B, Sauer S, Meyer TF.

Nat Cell Biol. 2019 Jul;21(7):812-823. doi: 10.1038/s41556-019-0339-9. Epub 2019 Jun 24.

PMID:
31235935
7.

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future.

Stueven AK, Kayser A, Wetz C, Amthauer H, Wree A, Tacke F, Wiedenmann B, Roderburg C, Jann H.

Int J Mol Sci. 2019 Jun 22;20(12). pii: E3049. doi: 10.3390/ijms20123049. Review.

8.

Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab.

Stüven AK, Wiedenmann B.

Oncotarget. 2019 May 14;10(35):3302-3311. doi: 10.18632/oncotarget.26906. eCollection 2019 May 14.

9.

Malnutrition predicts long-term survival in hospitalized patients with gastroenterological and hepatological diseases.

Knappe-Drzikova B, Maasberg S, Vonderbeck D, Krafft TA, Knüppel S, Sturm A, Müller-Nordhorn J, Wiedenmann B, Pape UF.

Clin Nutr ESPEN. 2019 Apr;30:26-34. doi: 10.1016/j.clnesp.2019.02.010. Epub 2019 Mar 7.

PMID:
30904226
10.

Advanced liver function assessment in patients with intestinal failure on long-term parenteral nutrition.

Blüthner E, Bednarsch J, Pape UF, Karber M, Maasberg S, Gerlach UA, Pascher A, Wiedenmann B, Pratschke J, Stockmann M.

Clin Nutr. 2019 Mar 5. pii: S0261-5614(19)30093-7. doi: 10.1016/j.clnu.2019.02.039. [Epub ahead of print]

PMID:
30885502
11.

Determinants of Quality of Life in Patients With Intestinal Failure Receiving Long-Term Parenteral Nutrition Using the SF-36 Questionnaire: A German Single-Center Prospective Observational Study.

Blüthner E, Bednarsch J, Stockmann M, Karber M, Pevny S, Maasberg S, Gerlach UA, Pascher A, Wiedenmann B, Pratschke J, Pape UF.

JPEN J Parenter Enteral Nutr. 2019 Mar 13. doi: 10.1002/jpen.1531. [Epub ahead of print]

PMID:
30864177
12.

Reply to 'Time for a change and to adopt a novel molecular genomic approach in NETs'.

Rindi G, Wiedenmann B.

Nat Rev Clin Oncol. 2019 Apr;16(4):270. doi: 10.1038/s41571-019-0186-4. No abstract available.

PMID:
30809029
13.
14.

Neuroendocrine neoplasia goes molecular - time for a change.

Rindi G, Wiedenmann B.

Nat Rev Clin Oncol. 2019 Mar;16(3):149-150. doi: 10.1038/s41571-018-0118-8. No abstract available.

PMID:
30390038
15.

Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.

Rindi G, Klersy C, Albarello L, Baudin E, Bianchi A, Buchler MW, Caplin M, Couvelard A, Cros J, de Herder WW, Delle Fave G, Doglioni C, Federspiel B, Fischer L, Fusai G, Gavazzi F, Hansen CP, Inzani F, Jann H, Komminoth P, Knigge UP, Landoni L, La Rosa S, Lawlor RT, Luong TV, Marinoni I, Panzuto F, Pape UF, Partelli S, Perren A, Rinzivillo M, Rubini C, Ruszniewski P, Scarpa A, Schmitt A, Schinzari G, Scoazec JY, Sessa F, Solcia E, Spaggiari P, Toumpanakis C, Vanoli A, Wiedenmann B, Zamboni G, Zandee WT, Zerbi A, Falconi M.

Neuroendocrinology. 2018;107(4):375-386. doi: 10.1159/000494355. Epub 2018 Oct 9.

16.

Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms.

Baudin E, Hayes AR, Scoazec JY, Filosso PL, Lim E, Kaltsas G, Frilling A, Chen J, Kos-Kudła B, Gorbunova V, Wiedenmann B, Nieveen van Dijkum E, Ćwikła JB, Falkerby J, Valle JW, Kulke MH, Caplin ME; ENETS 2016 Munich Advisory Board Participants; ENETS 2016 Munich Advisory Board Participants.

Neuroendocrinology. 2019;108(1):7-17. doi: 10.1159/000493980. Epub 2018 Sep 24.

17.

Experience with teduglutide treatment for short bowel syndrome in clinical practice.

Pevny S, Maasberg S, Rieger A, Karber M, Blüthner E, Knappe-Drzikova B, Thurmann D, Büttner J, Weylandt KH, Wiedenmann B, Müller VA, Bläker H, Pascher A, Pape UF.

Clin Nutr. 2019 Aug;38(4):1745-1755. doi: 10.1016/j.clnu.2018.07.030. Epub 2018 Aug 2.

PMID:
30145039
18.

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.

Alvarez MJ, Subramaniam PS, Tang LH, Grunn A, Aburi M, Rieckhof G, Komissarova EV, Hagan EA, Bodei L, Clemons PA, Dela Cruz FS, Dhall D, Diolaiti D, Fraker DA, Ghavami A, Kaemmerer D, Karan C, Kidd M, Kim KM, Kim HC, Kunju LP, Langel Ü, Li Z, Lee J, Li H, LiVolsi V, Pfragner R, Rainey AR, Realubit RB, Remotti H, Regberg J, Roses R, Rustgi A, Sepulveda AR, Serra S, Shi C, Yuan X, Barberis M, Bergamaschi R, Chinnaiyan AM, Detre T, Ezzat S, Frilling A, Hommann M, Jaeger D, Kim MK, Knudsen BS, Kung AL, Leahy E, Metz DC, Milsom JW, Park YS, Reidy-Lagunes D, Schreiber S, Washington K, Wiedenmann B, Modlin I, Califano A.

Nat Genet. 2018 Jul;50(7):979-989. doi: 10.1038/s41588-018-0138-4. Epub 2018 Jun 18.

19.

Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines.

Exner S, Prasad V, Wiedenmann B, Grötzinger C.

Front Endocrinol (Lausanne). 2018 Apr 6;9:146. doi: 10.3389/fendo.2018.00146. eCollection 2018.

20.

Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: results of a multicenter retrospective cohort study.

Turowski F, Hügle U, Dormann A, Bechtler M, Jakobs R, Gottschalk U, Nötzel E, Hartmann D, Lorenz A, Kolligs F, Veltzke-Schlieker W, Adler A, Becker O, Wiedenmann B, Bürgel N, Tröger H, Schumann M, Daum S, Siegmund B, Bojarski C.

Surg Endosc. 2018 Sep;32(9):3981-3988. doi: 10.1007/s00464-018-6141-0. Epub 2018 Mar 12.

PMID:
29532224
21.

Extremely Long Survival under Combined Immunotherapy in a Metastatic Functional Neuroendocrine Neoplasia Patient.

Schmidt D, Wiedenmann B.

Neuroendocrinology. 2018;106(4):381-388. doi: 10.1159/000486417. Epub 2017 Dec 20.

22.

CapsoCam SV-1 Versus PillCam SB 3 in the Detection of Obscure Gastrointestinal Bleeding: Results of a Prospective Randomized Comparative Multicenter Study.

Zwinger LL, Siegmund B, Stroux A, Adler A, Veltzke-Schlieker W, Wentrup R, Jürgensen C, Wiedenmann B, Wiedbrauck F, Hollerbach S, Liceni T, Bojarski C.

J Clin Gastroenterol. 2019 Mar;53(3):e101-e106. doi: 10.1097/MCG.0000000000000994.

PMID:
29369240
23.

Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus.

Genç CG, Klümpen HJ, Denecke T, Wiedenmann B, Pavel M.

Acta Oncol. 2018 May;57(5):686-688. doi: 10.1080/0284186X.2017.1398410. Epub 2017 Nov 10. No abstract available.

PMID:
29126357
24.

Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis.

Sigal M, Logan CY, Kapalczynska M, Mollenkopf HJ, Berger H, Wiedenmann B, Nusse R, Amieva MR, Meyer TF.

Nature. 2017 Aug 24;548(7668):451-455. doi: 10.1038/nature23642. Epub 2017 Aug 16.

PMID:
28813421
25.

ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers.

Oberg K, Couvelard A, Delle Fave G, Gross D, Grossman A, Jensen RT, Pape UF, Perren A, Rindi G, Ruszniewski P, Scoazec JY, Welin S, Wiedenmann B, Ferone D; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):201-211. doi: 10.1159/000472254. Epub 2017 Apr 8. No abstract available.

26.

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging.

Sundin A, Arnold R, Baudin E, Cwikla JB, Eriksson B, Fanti S, Fazio N, Giammarile F, Hicks RJ, Kjaer A, Krenning E, Kwekkeboom D, Lombard-Bohas C, O'Connor JM, O'Toole D, Rockall A, Wiedenmann B, Valle JW, Vullierme MP; Antibes Consensus Conference participants.

Neuroendocrinology. 2017;105(3):212-244. doi: 10.1159/000471879. Epub 2017 Mar 30. No abstract available.

PMID:
28355596
27.

Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications.

Merola E, Pavel ME, Panzuto F, Capurso G, Cicchese N, Rinke A, Gress TM, Iannicelli E, Prosperi D, Pizzichini P, Prasad V, Kump P, Lipp R, Partelli S, Falconi M, Wiedenmann B, Delle Fave G.

J Clin Endocrinol Metab. 2017 May 1;102(5):1486-1494. doi: 10.1210/jc.2016-3732.

PMID:
28324047
28.

Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome.

Panzuto F, Merola E, Pavel ME, Rinke A, Kump P, Partelli S, Rinzivillo M, Rodriguez-Laval V, Pape UF, Lipp R, Gress T, Wiedenmann B, Falconi M, Delle Fave G.

Oncologist. 2017 Apr;22(4):409-415. doi: 10.1634/theoncologist.2016-0351. Epub 2017 Feb 23.

29.

Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia.

Maasberg S, Knappe-Drzikova B, Vonderbeck D, Jann H, Weylandt KH, Grieser C, Pascher A, Schefold JC, Pavel M, Wiedenmann B, Sturm A, Pape UF.

Neuroendocrinology. 2017;104(1):11-25. Epub 2015 Dec 8.

30.

EndoClot Polysaccharide Hemostatic System in Nonvariceal Gastrointestinal Bleeding: Results of a Prospective Multicenter Observational Pilot Study.

Prei JC, Barmeyer C, Bürgel N, Daum S, Epple HJ, Günther U, Maul J, Siegmund B, Schumann M, Tröger H, Stroux A, Adler A, Veltzke-Schlieker W, Jürgensen C, Wentrup R, Wiedenmann B, Binkau J, Hartmann D, Nötzel E, Domagk D, Wacke W, Wahnschaffe U, Bojarski C.

J Clin Gastroenterol. 2016 Nov/Dec;50(10):e95-e100.

PMID:
27552329
31.

Management of follow-up of neuroendocrine neoplasias.

Pape UF, Maasberg S, Jann H, Pschowski R, Krüger S, Prasad V, Denecke T, Wiedenmann B, Pascher A.

Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):129-40. doi: 10.1016/j.beem.2016.02.001. Epub 2016 Feb 23. Review.

PMID:
26971849
32.

[Endoscopic therapy for gastroduodenal neuroendocrine neoplasms].

Maasberg S, Jürgensen C, Scheerer F, Pschowski R, Felder S, Begum N, Wiedenmann B, Pascher A, Pape UF.

Chirurg. 2016 Apr;87(4):271-9. doi: 10.1007/s00104-016-0157-6. Review. German.

PMID:
26960437
33.

Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia.

Pschowski R, Pape UF, Fusch G, Fischer C, Jann H, Baur A, Arsenic R, Wiedenmann B, von Haehling S, Pavel M, Schefold JC.

Neuroendocrinology. 2017;104(2):135-144. Epub 2016 Mar 9.

34.

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.

Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, Sedlackova E, Toumpanakis C, Anlauf M, Cwikla JB, Caplin M, O'Toole D, Perren A; Vienna Consensus Conference participants.

Neuroendocrinology. 2016;103(2):186-94. doi: 10.1159/000443172. Epub 2016 Jan 5. No abstract available.

35.

Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior.

Rosentraeger MJ, Garbrecht N, Anlauf M, Raffel A, Knoefel WT, Wiedenmann B, Klöppel G.

Virchows Arch. 2016 Mar;468(3):277-87. doi: 10.1007/s00428-015-1890-9. Epub 2015 Dec 9.

PMID:
26649731
36.

A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics.

Sadanandam A, Wullschleger S, Lyssiotis CA, Grötzinger C, Barbi S, Bersani S, Körner J, Wafy I, Mafficini A, Lawlor RT, Simbolo M, Asara JM, Bläker H, Cantley LC, Wiedenmann B, Scarpa A, Hanahan D.

Cancer Discov. 2015 Dec;5(12):1296-313. doi: 10.1158/2159-8290.CD-15-0068. Epub 2015 Oct 7.

37.

Staged Catheter-Based Valve Treatment of Severe Carcinoid Heart Disease.

Laule M, Pschowski R, Pape UF, Pavel M, Stangl V, Baumann G, Wiedenmann B, Stangl K.

Neuroendocrinology. 2016;103(3-4):259-62. doi: 10.1159/000437167. Epub 2015 Jun 30.

PMID:
26138598
38.

Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours.

Dilz LM, Denecke T, Steffen IG, Prasad V, von Weikersthal LF, Pape UF, Wiedenmann B, Pavel M.

Eur J Cancer. 2015 Jul;51(10):1253-62. doi: 10.1016/j.ejca.2015.04.005. Epub 2015 Apr 29.

PMID:
25935542
39.

An outbreak of carbapenem-resistant OXA-48 - producing Klebsiella pneumonia associated to duodenoscopy.

Kola A, Piening B, Pape UF, Veltzke-Schlieker W, Kaase M, Geffers C, Wiedenmann B, Gastmeier P.

Antimicrob Resist Infect Control. 2015 Mar 25;4:8. doi: 10.1186/s13756-015-0049-4. eCollection 2015.

40.

Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial.

Pavel M, Hörsch D, Caplin M, Ramage J, Seufferlein T, Valle J, Banks P, Lapuerta P, Sands A, Zambrowicz B, Fleming D, Wiedenmann B.

J Clin Endocrinol Metab. 2015 Apr;100(4):1511-9. doi: 10.1210/jc.2014-2247. Epub 2015 Jan 30.

PMID:
25636046
41.

Near-Infrared Confocal Laser Endomicroscopy Detects Colorectal Cancer via an Integrin αvβ 3 Optical Probe.

Schulz P, Dierkes C, Wiedenmann B, Grötzinger C.

Mol Imaging Biol. 2015 Aug;17(4):450-60. doi: 10.1007/s11307-015-0825-9.

PMID:
25622811
42.

Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform.

Kidess E, Heirich K, Wiggin M, Vysotskaia V, Visser BC, Marziali A, Wiedenmann B, Norton JA, Lee M, Jeffrey SS, Poultsides GA.

Oncotarget. 2015 Feb 10;6(4):2549-61.

43.

Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany.

Adler A, Geiger S, Keil A, Bias H, Schatz P, deVos T, Dhein J, Zimmermann M, Tauber R, Wiedenmann B.

BMC Gastroenterol. 2014 Oct 17;14:183. doi: 10.1186/1471-230X-14-183.

44.

The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis.

Benito de Valle M, Müller T, Björnsson E, Otten M, Volkmann M, Guckelberger O, Wiedenmann B, Sadik R, Schott E, Andersson M, Berg T, Lindkvist B.

Dig Liver Dis. 2014 Oct;46(10):903-8. doi: 10.1016/j.dld.2014.06.010. Epub 2014 Aug 1.

PMID:
25091876
45.

Glucagon regulates orexin A secretion in humans and rodents.

Arafat AM, Kaczmarek P, Skrzypski M, Pruszyńska-Oszmałek E, Kołodziejski P, Adamidou A, Ruhla S, Szczepankiewicz D, Sassek M, Billert M, Wiedenmann B, Pfeiffer AF, Nowak KW, Strowski MZ.

Diabetologia. 2014 Oct;57(10):2108-16. doi: 10.1007/s00125-014-3335-4. Epub 2014 Jul 27.

PMID:
25063274
46.

MRI-guided percutaneous transhepatic cholangiodrainage: feasibility study in a porcine model.

Papanikolaou IS, van der Voort IR, Chopra SS, Seebauer CJ, Rump J, Papas MG, Triantafyllou K, Baumgart DC, Teichgräber UK, Wiedenmann B, Rösch T.

Scand J Gastroenterol. 2014 Jun;49(6):722-6. doi: 10.3109/00365521.2014.899619. Epub 2014 Apr 2.

PMID:
24694300
47.

[Neuroendocrine neoplasms of the distal jejunum and ileum].

Anlauf M, Sipos B, Boeck I, Baldus SE, Heikaus S, Krausch M, Knoefel WT, Begum N, Goretzki P, Schott M, Auernhammer CJ, Cremer B, Rinke A, Ezziddin S, Fottner C, Pöpperl G, Lahner H, Hörsch D, Gabbert HE, Komminoth P, Perren A, Klöppel G, Wiedenmann B, Pavel M, Pape U.

Pathologe. 2014 May;35(3):283-93; quiz 294. doi: 10.1007/s00292-013-1888-5. Review. German.

PMID:
24671468
48.

A rare cause of peripheral arthralgia in inflammatory bowel disease: multifocal osteonecrosis.

Grunert PC, Collettini F, Perka C, Zeitz M, Wiedenmann B, Büning C.

Z Gastroenterol. 2014 Mar;52(3):285-9. doi: 10.1055/s-0034-1365933. Epub 2014 Mar 12. Review.

PMID:
24622871
49.

Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer.

Göhrig A, Detjen KM, Hilfenhaus G, Körner JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B, Fischer C.

Cancer Res. 2014 Mar 1;74(5):1529-40. doi: 10.1158/0008-5472.CAN-13-1012. Epub 2014 Jan 21.

50.

Systemic therapeutic strategies for GEP-NETS: what can we expect in the future?

Raymond E, García-Carbonero R, Wiedenmann B, Grande E, Pavel M.

Cancer Metastasis Rev. 2014 Mar;33(1):367-72. doi: 10.1007/s10555-013-9467-z. Review.

PMID:
24375390

Supplemental Content

Loading ...
Support Center